Nonarterialized orthotopic liver transplantation with no immunosuppression was performed in 13 mouse-strain combinations. Two strain combinations with major histocompatibility complex class I and class II and minor histocompatibility complex disparity had 20% and 33% survival of more than 100 days, but the other 11 combinations, including four that were fully allogeneic and all with only class I, class II or minor disparities, yielded 45% to 100% survival of more than 100 days. Long-living recipients permanently accepted donor-strain heterotopic hearts transplanted on the same day or donor-strain skin 3 mo after liver transplantation, in spite of detectable antidonor in vitro activity with mixed lymphocyte reaction and cellmediated lymphocytoto:s:icity testing (split tolerance). In further donor-specific experiments, liver grafts were not rejected by presensitized m.qor histocompatibility complex clasa I-disparate recipients and they protected donor-strain skin grafts from second set (or any) rejection. Leu frequently, liver transplantation rescued rejecting skin grafts placed 1 wk earlier in m.qor histocompatibility complex class I, class II and minor histocompatibility complex, class II or minor histocompatibility complex-disparate strain combinations. Donor·derived leukocyte migration to the central lymphoid organs occurred within 1 to 2 hr after liver transplantation in all animals examined, persisted in the surviving animals until they were killed (> 375 days), and was demonstrated with double-immunolabeling to be multilineage. The relation of these findings to so-called hepatic tolerogenicity and to tolerance in general is discussed. (HEPATOLOGY 1994;19: 916-924.) We have proposed that a reciprocal migration of leukocytes of bone marrow origin between graft and host, with subsequent chimerism in both, is the first step toward donor-specific nonreactivity (tolerance) that may or may not require immunosuppression (1-7). According to this concept, the variable tolerogenicity and ease of "acceptance" of different organs merely reflect the
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MATERIALS AND METHODS

Animals and Procedurell
Ten-to 12-wk-old male mice with varying H-2 histocompatibility genotypes (Table 1) were purchased from the Jackson Laboratory (Bar Harbor, ME) and housed in a pathogen-free facility. All operations and procedures were carried out with mice under methoxyflurane (2.2-dichloro-1,l-difluoroethyl methyl ether) anesthesia.
Liver TraJUlplGntation. The allograft was placed in the normal location after removal of the recipient's liver. It was revascularized with a combination of suture and cuff techniques. The hepatic artery was not reconstructed.. This operation has been described. in detail elsewhere (10) and is fundamentally the same as developed. first in dogs (11) and human beings (12) , and then used experimentally in pigs (13) and other large animals. In mice (10) and rats (14) , hepatic arterialization is not necessary. Cholecystectomy was performed., and bile duct patency was assured with a fine polyethylene tube stent. Immunosuppression was not used. Animals that died within 1 week after transplantation were classified. as technical failures (10% to 15% of total operations) and excluded from analysis. Tissues were usually harvested. after the animal had been killed, but in some cases wed.ge resection biopsies of the liver were performed at reoperation without the animals being killed.
Hearl Tra""plGntation. The intraabdominal operation was adapted. from the rat procedure ofOno and Lindsey (15) , with daily monitoring of the heart grafts by palpation through the abdominal wall. Rejection was defined. by the cessation of cardiac impulses and confirmed by exploration and histological examination.
Skin TraJUlplantation. A full-thickness skin graft from the donor tail (8 mm x 8 mm) was placed on the recipient's dorsal side by the method of Billingham et aI. (16l. The graft was held in place by the dressing and a tape for 7 to 8 days and inspected daily thereafter. Rejection was defined as the day of complete graft destruction.
Tisllue Collections
With the few exceptions in which wed.ge biopsies were performed. the liver recipients were killed 1 hr to more than 
ImmulWhistochemical Staining
Donor cells were localized within the recipient tissues and the liver allografts with the use of a direct immunoperoxidase procedure. Endogenous biotin was blocked with the avidin· biotin blocking reagent (Vector Laboratories, Inc., Bur· lingame, CAl for 20 min each. The tissues were incubated with nonfat dried milk for 20 min and, after two washes with PBS, were reacted for 45 min with the biotinylated donor·specific class I or class II monoclonal antibodies or an isotype·matched biotinylated control (negative-staining control) and then washed in PBS (twice for 5 min). Endogenous peroxidase activity in the tissues was then quenched with 0.6% H 2 0 2 for 4 min and washed in PBS (twice for 5 min). The primary antibody was localized with streptavidin-conjugated per· oxidase for 30 min and washed in PBS (twice for 5 min), and the reaction was developed with 3-amino-5·ethycarbizol (9 min). The slides were counterstained with Harris' hematoxylin and mounted with Gelvatol (Monsanto, St. Louis, MOl.
A double immunofluorescence (DIF) procedure was used to identify the lineages of donor cells in recipient tissues and grafted livers. The procedure adopted to localize donor cells was identical to immunoperoxidase staining, except that endogenous peroxidase activity was not quenched, and biotin· ylated primary monoclonal antibody was visualized with streptavidin·conjugated Cy3 (Jackson Immunoresearch Labo· ratories, Inc., West Grove, PAl.
After localization of the donor cells with the use of antidonor MHC class I or II antibodies (with the above DIF technique), IgM + cells were identified by use of FITC.conjugated goat anti mouse IgM (IJ. chain specific). T cells, B cells, macrophages and dendritic cell lineages were identified by use of an indirect IF technique with the rat monoclonal antibodies to mouse shown in Table 2 . These primary immunoreactants were then visualized by using mouse-adsorbed, FITC·conjugated goat antirat IgG. Donor class I or II positive cells that were negative for the specific lineage marker being tested were stained pure red. Cells of the recipient origin and bearing the appropriate lineage marker stained green, whereas donor cells expressing the appropriate lineage stained yellow. In some of the immunolabeling studies. class I and II surface antigen expression was augmented by an intraperitoneal injection of 4 x 10 6 units of recombinant interferon·'Y (rinterferon-'Y) (Schering·Plough, Kenilworth. NJ) 2 days before the animal was killed. Interferon-'Y pretreatment did not change the pattern of chimerism, but it facilitated the ease of recognition of donor cells in long-term allograft recipients. The technique has been reported elsewhere \ 17).
In Vitro Immunologic Tests
Unidirectional mixed lymphocyte reaction was measured in recipients from nonreJecting strain combinations that were killed 30 days after liver transplantation for immunohistochemical studies. Irradiated (20 Gy) donor and third-party lymphocytes were used as stimulators and cells isolated from the recipients' spleens as responders. In addition. the cytolytic activity of the recipient's splenic lymphocytes toward donor and third-party targets was assessed in cell-mediated lympholysis (CML) assays. Effector lymphocytes were incubated with [; lCr-labeled target cells at 100: 1 effector/target ratios. More complete studies over the whole range of survival are reported elsewhere (18) . (Table 3 ), but even in these groups 20% and 33%, respectively, of recipients (disparate at class I, class II and minor histocompatibility complex) had survival of more than 100 days. Fifty-five of 78 liver recipients in the other 11 groups whose donors had histocompatibility disparities ranging from fully allogeneic to minor survived more than 100 days. This outcome was accomplished more regularly when there was MHC class I and II or class II compatibility (Table  3 ), the strain combinations of which essentially all animals had permanent survival. However, 70% or better survival was also recorded in several strain combinations with disparate MHC class II, class I or both.
The results were influenced by the strain direction of the organ transfer. C3H~BlO transplantations fared badly (1 in 5 liver grafts accepted more than 100 days), whereas with BlO~C3H 10 of 12 had more than 100-day survival. A smaller directional influence was seen with the A.TH~A.TL class II combination (Table 3) ,
Hepatic Tolerogenicity
Mter we determined the most predictably nonrejecting strain combinations by the foregoing studies, four pairings covering the spectrum of histoincompatibility were selected for studies of hepatic tolerogenicity for other grafts.
Skin Transplantation. Three months after successful liver transplantation, donor-strain skin grafts were accepted no matter what the MHC disparity, with only two exceptions in a total of 15 mice (Table 4) , The delayed skin transplantations did not adversely affect the preexisting liver allografts. All third-party skin grafts were rejected at the expected times.
No OL1" 7.7,7,7,7,10,10 9,11,19,22,23
Heart 8UJ'Vival (days) With OLT > 100, > 100 > 100, > 100 9.25, > 100, > 100. > 100 13,13,13,13.14 > 100. > 100. > 100
In 10 additional experiments with total, class II and minor incompatibilities, liver transplantation from the same donor strain was performed 7 days after rather than before skin transplantation. Four of the 10 skin grafts were rescued from their expected fate of rejection (which normally occurred at about 2 to 3 wk), but this outcome was accomplished more than once only with the BI0.BR~C3H strain combination, which is minor histocompatibility complex incompatible (Table 5) .
In further sensitization experiments with the class I-disparate BlO.AKM~BlO.BR strains, accelerated rejection was produced by repeat skin grafts ( Table 6 ). The second-set rejections were prevented in nine of nine experiments by an intervening BlO.AKM liver transplantation, which erased the memory of the previous exposure; eight of the nine skin grafts survived permanently (Table 6) .
Heart Transplantation. Strong hepatic tolerogenicity was observed when donor-strain heart was transplanted on the same day as liver replacement. Instead of being rejected after 7 to 23 days (variable with different MHC disparities), all of the hearts protected by concomitantly transplanted livers survived permanently (Table 7) .
Similar experiments were planned with the class I disparity of BI0.AKM~BlO.BR. However, the control cardiac grafts were permanently accepted by three of the five normal BlO.BR mice (Table 7) . This self-induction of tolerance by the heart made hepatic tolerogenicity studies impossible.
Histopathologic Evidence of Chimerism
Systemic chimerism was looked for in the organs of liver recipients 7 mo after transplantation in fully disparate BlO~C3H (class I, II, minor disparate) combinations. Sparse donor-specific class 1-or class II-positive cells could always be found. They were most easily detectable in the recipient's lymphoid organs (spleen, mesenteric lymph nodes and thymus ) (Figs. 1, 2 and 3 ) . Donor cells were also identified in small numbers in the recipients' peripheral lymph nodes, small bowel, skin, kidney, tongue, heart and lung.
The migrant donor cells found in recipient tissues long after transplantation were detected by double immunolabeling using antidonor MHC class I or II mAb and lineage-restricted leukocyte markers. The phenotype of donor cells identified included B cells (B220 and IgM positive), T cells (Thy 1.2 positive), macrophages (Ml170 and F4/80 positive) and dendritic cells (NLDC-145 and 2A1 positive). B cells were the most frequently detectable chimeric cells (about 60% of total), followed by T cells, dendritic cells and macrophages. These cells were the same lineages as demonstrated with flow cytometric analysis of nonparenchymal cells isolated from normal mouse liver (18) . The multilineage nature of the chimerism was evident at all time points tested.
The chimeric B cells (Fig. 3A) were detected mainly in the B-cell follicles of the recipient spleen. Analogous homing of donor B cells to normal sites of trafficking was also noted in lymph nodes. Donor dendritic cells and T cells were most frequently located in the splenic periarterial lymphatic sheath, mingled with recipient T cells and dendritic cells (Fig. 3B and C) .
In Vitro Immunologic Reactivity
Splenocytes of C3H recipients of B10 livers showed alloreactivity toward the irradiated spleen cells of both the donor (B10) and third-party (BALB/C) animals. The alloreactivity was similar to that oflymphocytes isolated from naive C3H animals ( Table 8 ). The cell-mediated lymphotoxicity (CMU activity (CMU of the stimulated HEPATOLOGY April J 994 splenocytes from the liver-transplanted mice 30 days after transplantation was essentially the same against donor and third-party targets, whereas the killing of syngeneic targets was less than 10% ( Table 9 ). The antidonor immunologic reactivity was maintained throughout the observation period from wk 1 through wk 12 in our study.
DISCUSSION
An unanticipated advantage of the mouse liver transplantation model was that permanent graft acceptance could be achieved in all strain combinations without immunosuppression and reliably so with most. Failure of success to correlate with class I MHC compatibility was non supportive of an earlier hypothesis that secretion by the liver of new soluble class I antigens is the basis of its tolerogenicity (19) . The acceptance selfinduced by the liver extended, to other donor-strain tissues and organs, and could be used to rescue them from a second-set rejection caused by previous sensitization or less frequently from ongoing rejection _ Thus, the full spectrum of "hepatic tolerogenicity" (5, 6, 20) was exhibited in the absence of immunosuppression . Liver transplantation without treatment is also possible in a few rat-strain combinations (14, 21, 22) but not in outbred large animals (including human beings) with the exception of pigs (13, 20, 23 , 24) .
The ability to induce tolerance is not unique to the liver, only much stronger than that possessed by other organs (1-6) . Russell et al. (25 ) showed that mice that permanently accepted weakly histoincompatible kidneys without treatment were subsequently tolerant of skin from the donor strain. Corry et al. (26) described a mouse-strain combination that was nonrejecting for hearts, similar to one of our heart experiments in which there was an MHC class I disparity (BIO.AKlV1~ B10.BR). Though chimerism was not looked for in these earlier experiments, it is now the presumed explanation for the unexpected historical results.
The association of hematolymphopoietic chimerism with acquired tolerance (15, 27 ) and graft vs . host disease (28) was discovered by Billingham et al . (27) . The cause-and-effect relation was formally verified by Russell (29) , who reversed both tolerance and runt disease (graft-vs.-host disease) in the Billingham et al. (27) model by the simple expedient of eliminating the chimerism with antidonor leukocyte antibodies . However, because chimerism was not realized to be a feature of successful whole-organ transplantation, it has been widely assumed that the" acceptance" of organ grafts is by different mechanisms than successfully engrafted bone marrow. Revision of this entrenched misconception has been mandated by the recent demonstration with sensitive cytostaining and polymerase chain reaction techniques that microchimerism is invariably present after successful whole-organ transplantation in human beings (1-6) and rats (7) .
In fact, the microchimerism observed in our mouse liver transplant experiments (reported here) was strik- signaled the impending disappearance of these leukocytes obscured the importance of the early work. In addition, it was not remotely suspected, until our recent clinical (1-6) and experimental (7) studies, that the finding of microchimerism after bone marrow infusion is mimicked by migratory donor leukocytes from whole organs. For the low-level chimerism (usually < 0 .1 %) to have a potent and sustained tolerogenic effect, an amplification process is required. Our hypothesis (5, 7, 35) is that the donor leukocytes of bone marrow origin that are contained in all whole organs represent a functional fragment of the donor immune bEffector cells isolated from either naive or liver transplant recipients were initially cultured for 4 days with "I-irradiated splenocytes from either naive syngeneic (C3 H ), donor (BI0) or third party (BALB/C) animals and finally incubated with 51Cr-labelled syngeneic, donor and third-party target cells at an E : T ratio of 100 : 1. system, which for successful transplantation must be incorporated into the recipient's immune apparatus with receptor-ligand interactions of variable and changeable affinities.
In this "network" viewpoint (36) (37) (38) (39) (40) , bidirectional redefinition of self by the coexisting immune systems is not unreasonable, nor is the possibility of their eventual cooperation and complete mutual assimilation. The contention of Coutinho (37) that immunologic selfdefinition is maintained by self-assertion is compatible with our experimental evidence in rats (7) and in our more complete studies of the mouse liver model. These studies have not shown clonally deleted recipient populations but suggest instead a state of low-grade reciprocal stimulation (1S).
The iterative and metadynamic properties implicit in such an immune network would explain not only the large influence of a small number of chimeric cells but also the donor specificity of the consequent tolerance. If the detached and assimilated fragment of the donor immune system is able to maintain the rest of its "self" in its new environment, a mirror image (recipient specific) effect would not be surprising, such as that implicit in the results of both our rat and mouse experiments. Arnold et al. (41) have speculated that donor-(or recipient-) specific nonreactivity is the end stage of a long process that cannot be accurately assessed in its evolution by current in vitro techniques (42) (43) (44) , This situation was epitomized in our mice, which were shown to have normal antidonor activity by mixed lymphocyte reaction or CML testing at a time when their liver allografts were beyond the danger of fatal rejection and already were capable of shielding other normally rejected donor-strain tissues and organs from immunologic injury (1S)' This phenomenon has been called "split tolerance" (45, 46) .
We believe that multilineage donor leukocyte chimerism is required for these changes in the immunologic environment to occur. Although the presence of dendritic cells was emphasized in our human cases (1-6) and rat liver transplant experiments (7), there was also morphological and functional evidence that T and B lymphocytes and macrophages were part of the chimeric population. A mixture of chimeric cell lineages in recipient tissues was demonstrated far more conclusively in the mouse experiments reported here, both early and late after liver transplantation. However, the exact quantitation of the lineage proportions at different time points remains to be done.
